These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28304311)

  • 1. Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation.
    Gazzina S; Archetti S; Alberici A; Bonomi E; Cosseddu M; Di Lorenzo D; Padovani A; Borroni B
    J Alzheimers Dis; 2017; 57(4):1185-1189. PubMed ID: 28304311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
    Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
    J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
    Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
    Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation.
    Cioffi SM; Galimberti D; Barocco F; Spallazzi M; Fenoglio C; Serpente M; Arcaro M; Gardini S; Scarpini E; Caffarra P
    J Alzheimers Dis; 2016 Sep; 54(2):717-21. PubMed ID: 27567822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia.
    Cerami C; Marcone A; Galimberti D; Villa C; Fenoglio C; Scarpini E; Cappa SF
    J Alzheimers Dis; 2013; 36(3):415-20. PubMed ID: 23624518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progranulin (GRN) Cys157LysfsX97 mutation is associated with nonfluent variant of primary progressive aphasia clinical phenotype.
    Caso F; Villa C; Fenoglio C; Santangelo R; Agosta F; Coppi E; Falautano M; Comi G; Filippi M; Scarpini E; Magnani G; Galimberti D
    J Alzheimers Dis; 2012; 28(4):759-63. PubMed ID: 22072213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
    Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A
    BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progranulin deficiency induces overactivation of WNT5A expression via TNF-α/NF-κB pathway in peripheral cells from frontotemporal dementia-linked granulin mutation carriers.
    Alquézar C; de la Encarnación A; Moreno F; López de Munain A; Martín-Requero Á
    J Psychiatry Neurosci; 2016 Jun; 41(4):225-39. PubMed ID: 26624524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant frontotemporal dementia mutations in 140 cases of primary progressive aphasia and speech apraxia.
    Flanagan EP; Baker MC; Perkerson RB; Duffy JR; Strand EA; Whitwell JL; Machulda MM; Rademakers R; Josephs KA
    Dement Geriatr Cogn Disord; 2015; 39(5-6):281-6. PubMed ID: 25765123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers.
    Galimberti D; Bonsi R; Fenoglio C; Serpente M; Cioffi SM; Fumagalli G; Arighi A; Ghezzi L; Arcaro M; Mercurio M; Rotondo E; Scarpini E
    Brain Behav Immun; 2015 Oct; 49():182-7. PubMed ID: 26021560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil.
    Takada LT; Bahia VS; Guimarães HC; Costa TV; Vale TC; Rodriguez RD; Porto FH; Machado JC; Beato RG; Cesar KG; Smid J; Nascimento CF; Grinberg LT; Brucki SM; Maximino JR; Camargos ST; Chadi G; Caramelli P; Nitrini R
    Alzheimer Dis Assoc Disord; 2016; 30(4):310-317. PubMed ID: 27082848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia.
    Calvi A; Cioffi SM; Caffarra P; Fenoglio C; Serpente M; Pietroboni AM; Arighi A; Ghezzi L; Gardini S; Scarpini E; Galimberti D
    J Alzheimers Dis; 2015; 44(1):277-82. PubMed ID: 25261445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
    Rohrer JD; Woollacott IO; Dick KM; Brotherhood E; Gordon E; Fellows A; Toombs J; Druyeh R; Cardoso MJ; Ourselin S; Nicholas JM; Norgren N; Mead S; Andreasson U; Blennow K; Schott JM; Fox NC; Warren JD; Zetterberg H
    Neurology; 2016 Sep; 87(13):1329-36. PubMed ID: 27581216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members.
    Finch N; Baker M; Crook R; Swanson K; Kuntz K; Surtees R; Bisceglio G; Rovelet-Lecrux A; Boeve B; Petersen RC; Dickson DW; Younkin SG; Deramecourt V; Crook J; Graff-Radford NR; Rademakers R
    Brain; 2009 Mar; 132(Pt 3):583-91. PubMed ID: 19158106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Progressive Aphasia Associated With
    Saracino D; Ferrieux S; Noguès-Lassiaille M; Houot M; Funkiewiez A; Sellami L; Deramecourt V; Pasquier F; Couratier P; Pariente J; Géraudie A; Epelbaum S; Wallon D; Hannequin D; Martinaud O; Clot F; Camuzat A; Bottani S; Rinaldi D; Auriacombe S; Sarazin M; Didic M; Boutoleau-Bretonnière C; Thauvin-Robinet C; Lagarde J; Roué-Jagot C; Sellal F; Gabelle A; Etcharry-Bouyx F; Morin A; Coppola C; Levy R; Dubois B; Brice A; Colliot O; Gorno-Tempini ML; Teichmann M; Migliaccio R; Le Ber I;
    Neurology; 2021 Jul; 97(1):e88-e102. PubMed ID: 33980708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, neuropathological, and genetic characteristics of the novel IVS9+1delG GRN mutation in a patient with frontotemporal dementia.
    Taipa R; Tuna A; Damásio J; Pinto PS; Cavaco S; Pereira S; Milterberger-Miltenyi G; Galimberti D; Melo-Pires M
    J Alzheimers Dis; 2012; 30(1):83-90. PubMed ID: 22366770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.
    Arrant AE; Filiano AJ; Unger DE; Young AH; Roberson ED
    Brain; 2017 May; 140(5):1447-1465. PubMed ID: 28379303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progranulin Gene Mutations in Chinese Patients with Frontotemporal Dementia: A Case Report and Literature Review.
    Chu M; Nan H; Jiang D; Liu L; Huang A; Wang Y; Wu L
    J Alzheimers Dis; 2023; 93(1):225-234. PubMed ID: 36970912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRN deletion in familial frontotemporal dementia showing association with clinical variability in 3 familial cases.
    Milan G; Napoletano S; Pappatà S; Gentile MT; Colucci-D'Amato L; Della Rocca G; Maciag A; Rossetti CP; Fucci L; Puca A; Grossi D; Postiglione A; Vitale E
    Neurobiol Aging; 2017 May; 53():193.e9-193.e16. PubMed ID: 28153380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
    Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A;
    Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.